VRAX (viraxbiolabs.com) Volume dana dhuwit perusahaan

Logo grafis viraxbiolabs.com (VRAX)

An IT platform for optimizing test distribution creates the foundation for growth for Virax Biolabs Group (VRAX). The current cash level on the GURU.Markets chart confirms this potential, where the 0.01 metric serves as the target level. External conditions are determined by the global biosecurity ecosystem featuring digital health passports, although falling demand for rapid diagnostics and the slow launch of new products are weighing on capital.

VRAX - Aset likuid perusahaan Virax Biolabs Group Ltd ing rentang 28.04.2023 - 21.11.2026

Rincian analitis perusahaan Virax Biolabs (VRAX)

Analisis komprehensif perusahaan:Virax Biolabs Group
Produk mawa merek viraxbiolabs.com

The optimized logistics for express tests at Virax Biolabs Group (VRAX) require the constant maintenance of high liquidity to cover air freight and warehousing operations. This process is digitized through the volume of free funds in accounts, eliminating dependence on external borrowings. This metric measures the actual capital reserve, determining the company's ability to instantaneously settle short-term liabilities. It is critical for investors to monitor the balance between security and resource efficiency. The price action of the cash-on-hand indicator clearly demonstrates the resilience of the financial cushion.

Perusahaan pesaing

Dhuwit awis perusahaan A (Agilent Tech)|Quest Diagnostics - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Illumina Corp ILMN|Aset likuid perusahaan Exact Sciences Corporation (EXAS)|RVTY: Dhuwit awis perusahaan|BIO: Dana dhuwit perusahaan|Anbio Biotechnology Ltd (NNNN) - Dana dhuwit perusahaan|soterahealth.com (SHC) - Volume dana dhuwit perusahaan|QDEL (QuidelOrtho Corporation) - Volume dana dhuwit perusahaan|OPK: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan CDNA|MRVI: Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan FLGT (Fulgent Genetics Inc)|Gunggung dana dhuwit perusahaan LAB (fluidigm.com)|Cytek Corp - Volume dana dhuwit perusahaan|OSUR (OraSure Technologies, Inc.) - Dhuwit awis lan setara dhuwit awis perusahaan|Exagen Diagnostics (XGN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan MDXH|LUCD (luciddx.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan PRE|Volume dana dhuwit perusahaan IMDX|TRIB (Trinity Biotech PLC) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan PRPH (ProPhase Labs Corp)|AIMD: Dhuwit awis lan setara dhuwit awis perusahaan|codiagnostics.com - Volume dana dhuwit perusahaan|heartsciences.com - Gunggung dana dhuwit perusahaan|Biomerica Inc. (BMRA) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Cardio Diagnostics Holdings Inc.|ONCO (onconetix.gcs-web.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan BJDX|Dhuwit awis perusahaan AWH (aspirawh.com)|Dhuwit awis perusahaan acceleratediagnostics.com AXDX|Volume dana dhuwit perusahaan CNTG (CENTOGENE N.V.)|ENZ: Dhuwit awis lan setara dhuwit awis perusahaan|FRES (fresh2.co) - Cadangan dhuwit perusahaan|GENE (gtglabs.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ME: Volume dana dhuwit perusahaan|PMD - Aset likuid perusahaan